Home
Atara Biotherapeutics ATRA paid King & Spalding $60K for lobbying in Q4 2023 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $60,000
- Quarter
- Q4 2023
- Client
- Atara Biotherapeutics
- Reported
- 24/01/16
Up 0.0% from last quarter
What else happened in Atara Biotherapeutics around then
Filed or reported within 30 days of the trade day · 23/12/01~24/01/30Atara Biotherapeutics's other lobbying reports
- Atara Biotherapeutics
LobbyingAtara Biotherapeutics
LobbyingAtara Biotherapeutics
ATRA
$10K
$10K
Reported 07/20
for Q2
- Atara Biotherapeutics
LobbyingAtara Biotherapeutics
LobbyingAtara Biotherapeutics
ATRA
Under $5,000
Under $5,000
Reported 25/07/21
for Q2 2025
- Atara Biotherapeutics
LobbyingAtara Biotherapeutics
LobbyingAtara Biotherapeutics
ATRA
$30K
$30K
Reported 25/04/21
for Q1 2025
- Atara Biotherapeutics
LobbyingAtara Biotherapeutics
LobbyingAtara Biotherapeutics
ATRA
$30K
$30K
Reported 25/01/14
for Q4 2024
- Atara Biotherapeutics
LobbyingAtara Biotherapeutics
LobbyingAtara Biotherapeutics
ATRA
$30K
$30K
Reported 24/10/21
for Q3 2024